The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design, validation ...

Genotyping tool is designed to detect genotypes related to 2C9*2, 2C9*3, and VKORC1 from a buccal swab. Mayo Clinic inked a deal with Rheonix to assess the performance of the company’s genotyping test ...

This is kind of an interesting project. I know warfarin sensitivity is a big deal in the med community, so this could a significant deal Mayo Medical Laboratories announced Monday that it is ...

ROCKVILLE, Md. - May 5, 2020 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations ...

March 16, 2010 (Atlanta, Georgia) — Genotyping warfarin patients resulted in a 30% reduction in all-cause hospitalizations and hospitalizations for bleeds/thromboemboli, a new study suggests. But ...

WASHINGTON (March 19, 2017) - Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse ...

Researchers have discovered a simple genetic test that helps doctors determine the best dose of the blood-thinner drug warfarin for individual patients could reduce hospitalizations by one-third ...

ATLANTA (Reuters) - Use of genetic screening on heart patients helped cut hospitalizations related to the widely used blood thinner warfarin by nearly a third, according to a large study that marks a ...

Northbrook, Ill - The US FDA has approved a new genetic test to help assess warfarin sensitivity [1]. The FDA notes that one-third of patients metabolize warfarin more slowly than others and therefore ...

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems ...